Stefan Norin
Patrimonio netto: 2 740 $ in data 31/05/2026
Patrimonio netto: 2 740 $ in data 31/05/2026
Stefan Norin currently works at Oncopeptides AB, as Chief Medical Officer from 2023.
Mr. Norin also formerly worked at Medivir AB, as Associate Director-Clinical Research & development from 2017 to 2019 and Karolinska University Hospital, as Head-Lymphosection.
Mr. Norin received his doctorate degree from Karolinska Institutet.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 19/03/2026 | 13.975 ( 0% ) | 2 740 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ONCOPEPTIDES AB | Direttore Tecnico/Scientifico/R&S | 01/09/2023 |
| Società | Posizione | Fine |
|---|---|---|
| MEDIVIR AB | Direttore Tecnico/Scientifico/R&S | 01/03/2019 |
Karolinska University Hospital
Karolinska University Hospital Hospital/Nursing ManagementHealth Services Provides hospital services | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Medivir AB
Medivir AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Karolinska University Hospital
Karolinska University Hospital Hospital/Nursing ManagementHealth Services Provides hospital services | Health Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale